comparemela.com

Page 5 - Kirsty Mcbain News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Webinar: Evaluation of checkpoint inhibitor therapies using a mixed lymphocyte reaction (MLR) assay

Webinar: Evaluation of checkpoint inhibitor therapies using a mixed lymphocyte reaction (MLR) assay
selectscience.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from selectscience.net Daily Mail and Mail on Sunday newspapers.

Webinars on fluorescence, confocal, and TIRF microscopy

Webinars on fluorescence, confocal, and TIRF microscopy
selectscience.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from selectscience.net Daily Mail and Mail on Sunday newspapers.

Evaluation of checkpoint inhibitor therapies using a mixed lymphocyte reaction (MLR) assay on SelectScience

10 Aug 2021 Immune checkpoints are molecules that signal and control the synapse between T cells and antigen presenting cells (APCs). Checkpoint inhibitor therapies aim to target and inhibit the signals that ‘switch off’ T cells, leading to upregulation of T cell activation and tumor cell killing. The mixed lymphocyte reaction (MLR) mimics the T cell and APC synapse by co-culturing immune cells from two individuals. Consequently, MLR is used as a model, to discover the effects of checkpoint inhibitor drugs in vitro, furthering biological research applications and drug discovery processes. Join this webinar to find out about: The use of the iQue

Top resources to advance your engineered antibody research

Special Feature: 10 top new resources to advance your engineered antibody research Explore our exclusive interviews, free downloads, latest methods, and much more to help support your antibody research 16 Mar 2021 As part of our new special feature, we’ve pulled together a selection of the top new resources to aid your work with engineered antibodies. Download our comprehensive guide to optimal antibody selection and application, discover the value of label-free technology for streamlined drug discovery workflows, explore the development of next-generation antibodies, and much more. Transform your immunoassay: Choose the right antibody for you In this interview, Dr. Christian Frisch, R&D manager at Bio-Rad Laboratories, explains how to design a reliable assay and reveals how Bio-Rad and Sartorius teamed up to help scientists achieve peak immunoassay performance. 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.